How States Use Cost-Growth Benchmark Programs to Contain Health Care Costs – NASHP
Updated May 31, 2024 A cost-growth benchmark program is a cost-containment strategy that limits how…
Related Articles
Japanese Encephalitis Virus Is A Threat to Travelers: Why and Who to Vaccinate
Is your patient at risk for Japanese encephalitis virus (JEV)?
Stable isotope evidence for pre-colonial maize agriculture and animal management in the Bolivian Amazon
Nature Human Behaviour – In the Bolivian Amazon, analyses of preserved human bone collagen show evidence of maize staple diets between ce 700 and 1400,…
Indiana State Senator Moves To Scrap Hospital Monopoly Law He Helped Create – KFF Health News
After rival hospitals in Terre Haute scuttled plans to merge, a state senator has introduced a bill to forbid similar mergers by repealing a state…
Embrace optimism for big emotional and physical benefits
“Research suggests that approaching life’s events with a more optimistic outlook can enhance physical health…” But that’s not all.
CES 2025: The Coolest New Tech and Gadgets We’ve Seen (So Far)
Including Samsung’s newest TVs, LG’s next-gen Ultrafine monitors, and a budget-friendly Apple Watch alternative.
Making Mayo’s Recipes: Six Grain Hot Cereal
Make a big batch of this cereal on the weekend and reheat all week. Top with fruit or yogurt to add natural sweetness. Full recipe:…
FDA News Month in Review: December 2024
In this edition of HCPLive’s newsletter on monthly US Food and Drug Administration (FDA) news, we cover updates from across therapeutic pipelines in December.
The power of business semantics: Turning data into actionable AI insights
The foundational challenge to successful AI insight is data fragmentation. Learn why business data fabric and business semantics are the key.
Two OTC continuous glucose monitors won awards at CES – and you can try them now
These over-the-counter CGMs from health brands Dexcom and Abbott make glucose monitoring affordable and accessible. Here’s how they can help you – no prescription necessary.
With a major patent cliff coming, will JPM play host to some serious deal-making?
The drug industry is facing one of the largest patent cliffs in recent history. Will that mean dealmaking at the annual J.P. Morgan Healthcare Conference.
